These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice. Quenelle DC; Collins DJ; Kern ER Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of cidofovir in a murine model of disseminated progressive vaccinia. Neyts J; Leyssen P; Verbeken E; De Clercq E Antimicrob Agents Chemother; 2004 Jun; 48(6):2267-73. PubMed ID: 15155231 [TBL] [Abstract][Full Text] [Related]
6. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864 [TBL] [Abstract][Full Text] [Related]
7. Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances. Smee DF; Bailey KW; Wong MH; Tarbet EB Antivir Chem Chemother; 2011 May; 21(5):201-8. PubMed ID: 21566266 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits. Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice. Neyts J; De Clercq E J Med Virol; 1993 Nov; 41(3):242-6. PubMed ID: 8263505 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794 [TBL] [Abstract][Full Text] [Related]
12. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Smee DF; Bailey KW; Wong MH; Sidwell RW Antiviral Res; 2001 Oct; 52(1):55-62. PubMed ID: 11530188 [TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of cidofovir resistant vaccinia viruses. Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW Virol J; 2008 May; 5():58. PubMed ID: 18479513 [TBL] [Abstract][Full Text] [Related]
14. A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge. Parker S; D'Angelo J; Buller RM; Smee DF; Lantto J; Nielsen H; Jensen A; Prichard M; George SL Antiviral Res; 2021 Nov; 195():105179. PubMed ID: 34530009 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Hopkins RJ; Lane JM Clin Infect Dis; 2004 Sep; 39(6):819-26. PubMed ID: 15472814 [TBL] [Abstract][Full Text] [Related]
16. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. Lederman ER; Davidson W; Groff HL; Smith SK; Warkentien T; Li Y; Wilkins KA; Karem KL; Akondy RS; Ahmed R; Frace M; Shieh WJ; Zaki S; Hruby DE; Painter WP; Bergman KL; Cohen JI; Damon IK J Infect Dis; 2012 Nov; 206(9):1372-85. PubMed ID: 22904336 [TBL] [Abstract][Full Text] [Related]
17. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. Smee DF; Wong MH; Bailey KW; Beadle JR; Hostetler KY; Sidwell RW Int J Antimicrob Agents; 2004 May; 23(5):430-7. PubMed ID: 15120719 [TBL] [Abstract][Full Text] [Related]